APA (7th ed.) Citation

Acharya, N., Sharma, S. K., Mishra, D., Dhooria, S., Dhir, V., & Jain, S. (2020). Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial. Rheumatology international, 40(5), 703-710. https://doi.org/10.1007/s00296-020-04565-w

Chicago Style (17th ed.) Citation

Acharya, Nupoor, Shefali Khanna Sharma, Debashish Mishra, Sahajal Dhooria, Varun Dhir, and Sanjay Jain. "Efficacy and Safety of Pirfenidone in Systemic Sclerosis-related Interstitial Lung Disease—a Randomised Controlled Trial." Rheumatology International 40, no. 5 (2020): 703-710. https://doi.org/10.1007/s00296-020-04565-w.

MLA (9th ed.) Citation

Acharya, Nupoor, et al. "Efficacy and Safety of Pirfenidone in Systemic Sclerosis-related Interstitial Lung Disease—a Randomised Controlled Trial." Rheumatology International, vol. 40, no. 5, 2020, pp. 703-710, https://doi.org/10.1007/s00296-020-04565-w.